CLYM
Financials
- Market Capitalization 836.85 M
- Employee 29
- Founded 2018
- CEO N/A
- Website www.climbbio.com
- Headquarter Delaware, United States
- FIGI BBG00ZNKL0K6
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2529 |  TBPH Theravance Biopharma, Inc. - Ordinary Shares | 17.05 USD | +0.06% | +0.35% | +1.13% | +18.82% | 885.21 M USD | ||
| 2551 |  RIGL Rigel Pharmaceuticals, Inc. - Common Stock | 46.48 USD | -0.81% | +1.86% | +20.70% | +54.26% | 868.24 M USD | ||
| 2583 |  ACHV Achieve Life Sciences, Inc. - Common Shares | 8.10 USD | -0.98% | +1.50% | +29.81% | +175.51% | 833.51 M USD | ||
| 2597 |  PHAR Pharming Group N.V. - ADS, each representing 10 | 11.70 USD | -1.27% | +0.69% | +20.37% | -14.66% | 820.97 M USD |
Frequently asked questions about Climb Bio, Inc. Common Stock
What is the Climb Bio, Inc. Common Stock stock price today?
The current price of Climb Bio, Inc. Common Stock (CLYM) is 14.57. Over the past 24 hours, the stock has changed by -3.25%. Follow the CLYM chart for real-time price dynamics.
What is the stock ticker of Climb Bio, Inc. Common Stock?
Climb Bio, Inc. Common Stock trades under the ticker CLYM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Climb Bio, Inc. Common Stock stock going up?
CLYM has changed by -11.59% over the last week, +17.59% over the last month, and +166.36% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Climb Bio, Inc. Common Stock?
Climb Bio, Inc. Common Stock currently has a market capitalization of 836.85 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Climb Bio, Inc. Common Stock earnings last quarter?
Last quarter, Climb Bio, Inc. Common Stock reported earnings of -0.18 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Climb Bio, Inc. Common Stock revenue for the last quarter?
Climb Bio, Inc. Common Stock reported quarterly revenue of 6 000. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Climb Bio, Inc. Common Stock net income for the last quarter?
Climb Bio, Inc. Common Stock reported net income of -13.5 M for the last quarter. The previous quarter showed -13.72 M, which means net income changed by +1.63%.
How many employees does Climb Bio, Inc. Common Stock have?
As of the latest available data, Climb Bio, Inc. Common Stock has 29 employees. Workforce size can provide additional context about the company's scale and operations.
What is Climb Bio, Inc. Common Stock EBITDA?
Climb Bio, Inc. Common Stock EBITDA is -15.32 M, and its EBITDA margin is -255.33 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Climb Bio, Inc. Common Stock stock?
You can buy Climb Bio, Inc. Common Stock (CLYM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Climb Bio, Inc. Common Stock stock?
Investing in Climb Bio, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CLYM chart and related analysis on metatrader.com as part of your research.